Voriconazole Tablets 50mg Recalled Due to CGMP Deviations
Glenmark Pharmaceuticals Inc. USA is recalling Voriconazole Tablets 50mg (Lot # 17231045, exp. date Apr-25) distributed nationwide due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for CGMP deviations. The source text does not report any illnesses, injuries, or confirmed adverse health consequences. Per the rubric, CGMP deviations without reported harm typically fall into the Moderate category.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is voluntarily recalling Voriconazole Tablets 50mg, 30-count bottles (NDC# 68462-572-30 and related package sizes) distributed nationwide. The recall affects Lot # 17231045 with an expiration date of April 2025.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations identified at the manufacturing facility. CGMP deviations can affect the quality and safety of pharmaceutical products.
The product was manufactured by Glenmark Pharmaceuticals Limited in Pithampur, Madhya Pradesh, India, and manufactured for Glenmark Pharmaceuticals Inc., USA in Mahwah, NJ. The recall is ongoing as of the latest report date.
Patients who have this medication should consult their physician or pharmacist before taking any action. Do not stop taking the medication without medical guidance, as voriconazole is a prescription antifungal medication used to treat serious fungal infections.
The recalled product
- Product
- VORICONAZOLE (VORICONAZOLE)
- Brand
- VORICONAZOLE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Antifungal / Prescription
- Hazard
- cgmp-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 17231045
- exp. date Apr-25
UPCs (1)
- 0368462573303
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · VORICONAZOLE
- ModeratePrescription Voriconazole Antifungal Tablets Recalled Nationwide for Manufacturing Deviations
FDA (Drugs) · 2025-04-16
- ModerateVoriconazole Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2025-04-09
- HighVoriconazole Oral Suspension Recalled for Missing Package Insert
FDA (Drugs) · 2024-02-28
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22